Slated to rise from 11th to 8th place in the global - TopicsExpress



          

Slated to rise from 11th to 8th place in the global pharmaceutical rankings, Russia is steadily proving to be a lucrative market for investors. With increased healthcare expenditure and governmental support of innovation through the implementation of Strategy 2020, policymaking and industry reform are shaping Russia’s drug development landscape. Efforts to localize pharmaceutical manufacturing and increase domestic R&D have been successful. Most of large pharma has set up camp in the country and remains present despite a drop in clinical trials in 2013.
Posted on: Fri, 17 Oct 2014 15:35:01 +0000

Trending Topics



we continue to hit the airways on Lifetime

Recently Viewed Topics




© 2015